These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 31604665)

  • 1. Viral load of human papillomavirus types 16/18/31/33/45 as a predictor of cervical intraepithelial neoplasia and cancer by age.
    Malagón T; Louvanto K; Ramanakumar AV; Koushik A; Coutlée F; Franco EL;
    Gynecol Oncol; 2019 Nov; 155(2):245-253. PubMed ID: 31604665
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Distribution of human papillomavirus genotypes in cervical intraepithelial neoplasia and invasive cervical cancer in Canada.
    Coutlée F; Ratnam S; Ramanakumar AV; Insinga RR; Bentley J; Escott N; Ghatage P; Koushik A; Ferenczy A; Franco EL
    J Med Virol; 2011 Jun; 83(6):1034-41. PubMed ID: 21503917
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term risk of cervical intraepithelial neoplasia grade 3 or worse according to high-risk human papillomavirus genotype and semi-quantitative viral load among 33,288 women with normal cervical cytology.
    Thomsen LT; Frederiksen K; Munk C; Junge J; Iftner T; Kjaer SK
    Int J Cancer; 2015 Jul; 137(1):193-203. PubMed ID: 25471319
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The association between human papillomavirus 16, 18 DNA load and E6 protein expression in cervical intraepithelial neoplasia and cancer.
    Wu Z; Yu L; Lei X; Qin Y; Zhang X; Chen W; Qiao Y
    J Clin Virol; 2018 Nov; 108():6-11. PubMed ID: 30196013
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human papillomavirus 16 load and E2/E6 ratio in HPV16-positive women: biomarkers for cervical intraepithelial neoplasia >or=2 in a liquid-based cytology setting?
    Boulet GA; Benoy IH; Depuydt CE; Horvath CA; Aerts M; Hens N; Vereecken AJ; Bogers JJ
    Cancer Epidemiol Biomarkers Prev; 2009 Nov; 18(11):2992-9. PubMed ID: 19861526
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Performance of carcinogenic human papillomavirus (HPV) testing and HPV16 or HPV18 genotyping for cervical cancer screening of women aged 25 years and older: a subanalysis of the ATHENA study.
    Castle PE; Stoler MH; Wright TC; Sharma A; Wright TL; Behrens CM
    Lancet Oncol; 2011 Sep; 12(9):880-90. PubMed ID: 21865084
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Triaging HPV-positive, cytology-negative cervical cancer screening results with extended HPV genotyping and p16
    Song F; Yan P; Huang X; Wang C; Qu X; Du H; Wu R
    BMC Infect Dis; 2021 Apr; 21(1):400. PubMed ID: 33931022
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of human papillomavirus genotyping for detecting high-grade intraepithelial neoplasia or cancer in HPV-positive women with normal cytology: a study from a hospital in northeastern China.
    Zhang J; Zhang D; Yang Z; Wang X; Wang D
    BMC Cancer; 2020 May; 20(1):443. PubMed ID: 32429919
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prophylactic vaccination against human papillomaviruses to prevent cervical cancer and its precursors.
    Arbyn M; Xu L; Simoens C; Martin-Hirsch PP
    Cochrane Database Syst Rev; 2018 May; 5(5):CD009069. PubMed ID: 29740819
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recurrent high-grade cervical lesion after primary conization is associated with persistent human papillomavirus infection in Norway.
    Vintermyr OK; Iversen O; Thoresen S; Quint W; Molijn A; de Souza S; Rosillon D; Holl K
    Gynecol Oncol; 2014 May; 133(2):159-66. PubMed ID: 24631451
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human papilloma virus testing in patient follow-up post cone biopsy due to high-grade cervical intraepithelial neoplasia.
    Almog B; Gamzu R; Kuperminc MJ; Levin I; Fainaru O; Niv J; Bar-Am A
    Gynecol Oncol; 2003 Mar; 88(3):345-50. PubMed ID: 12648585
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevalence of Human Papillomavirus Genotypes Among Women With High-Grade Cervical Lesions in Beijing, China.
    Xiao M; Xu Q; Li H; Gao H; Bie Y; Zhang Z
    Medicine (Baltimore); 2016 Jan; 95(3):e2555. PubMed ID: 26817906
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Evaluation of CIN2+ /CIN3+ risk of different HPV subtypes infection combined with abnormal cytology status].
    Luo HX; Du H; Liu ZH; Zhang LJ; Wang C; Wu RF
    Zhonghua Zhong Liu Za Zhi; 2018 Mar; 40(3):232-238. PubMed ID: 29575846
    [No Abstract]   [Full Text] [Related]  

  • 14. Human papillomavirus viral load in predicting high-grade CIN in women with cervical smears showing only atypical squamous cells or low-grade squamous intraepithelial lesion.
    Santos AL; Derchain SF; Martins MR; Sarian LO; Martinez EZ; Syrjänen KJ
    Sao Paulo Med J; 2003 Nov; 121(6):238-43. PubMed ID: 14989139
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diagnostic value of human papillomavirus (HPV) 16 and HPV18 viral loads for the detection of high-grade cervical intraepithelial neoplasia (CIN2+) in a cohort of African women living with HIV.
    Segondy M; Ngou J; Kelly H; Omar T; Goumbri-Lompo O; Doutre S; Mayaud P; Didelot MN
    J Clin Virol; 2018; 99-100():79-83. PubMed ID: 29353074
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Association between high risk human papillomavirus DNA load and cervical lesions in different infection status].
    Li TY; Wu ZN; Jiang MY; Cui JF; Liu B; Chen F; Chen W
    Zhonghua Zhong Liu Za Zhi; 2018 Jun; 40(6):475-480. PubMed ID: 29936777
    [No Abstract]   [Full Text] [Related]  

  • 17. Age-specific evaluation of primary human papillomavirus screening vs conventional cytology in a randomized setting.
    Leinonen M; Nieminen P; Kotaniemi-Talonen L; Malila N; Tarkkanen J; Laurila P; Anttila A
    J Natl Cancer Inst; 2009 Dec; 101(23):1612-23. PubMed ID: 19903804
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High-risk human papillomavirus DNA load in a population-based cervical screening cohort in relation to the detection of high-grade cervical intraepithelial neoplasia and cervical cancer.
    Hesselink AT; Berkhof J; Heideman DA; Bulkmans NW; van Tellingen JE; Meijer CJ; Snijders PJ
    Int J Cancer; 2009 Jan; 124(2):381-6. PubMed ID: 19003961
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cervical adenocarcinoma in situ: Human papillomavirus types and incidence trends in five states, 2008-2015.
    Cleveland AA; Gargano JW; Park IU; Griffin MR; Niccolai LM; Powell M; Bennett NM; Saadeh K; Pemmaraju M; Higgins K; Ehlers S; Scahill M; Johnson Jones ML; Querec T; Markowitz LE; Unger ER;
    Int J Cancer; 2020 Feb; 146(3):810-818. PubMed ID: 30980692
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Type-dependent association between risk of cervical intraepithelial neoplasia and viral load of oncogenic human papillomavirus types other than types 16 and 18.
    Fu Xi L; Schiffman M; Ke Y; Hughes JP; Galloway DA; He Z; Hulbert A; Winer RL; Koutsky LA; Kiviat NB
    Int J Cancer; 2017 Apr; 140(8):1747-1756. PubMed ID: 28052328
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.